This was the stock's third consecutive day of gains.
Argus upgraded shares of Baxter International (NYSE:BAX – Free Report) from a hold rating to a buy rating in a report issued ...
Argus upgraded Baxter (BAX) to Buy from Hold with a $40 price target Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...
Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...
Key Takeaways Baxter International shares soared Thursday after the company's fourth-quarter results topped estimates.The ...
Baxter International’s largest manufacturing plant is back up to regular production levels nearly five months after it was ...
A Baxter International intravenous manufacturing plant in North Carolina is back up and running at full capacity after it ...
Shares of Baxter International (NYSE:BAX) traded higher in the premarket on Thursday after the medical product maker reported ...
Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...
It fits big tires, has tons of options, and is highly adjustable. Perfect for adventure bikes, the MRP Baxter is ready for ...
In a report released on February 21, Vijay Kumar from Evercore ISI maintained a Buy rating on Baxter International (BAX – Research Report), ...
Kaizer Chiefs will assess their managerial situation at the end of the season. Nabi might be in trouble if they don’t secure Nedbank Cup glory.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results